Cited by 108Systemic Sclerosis and Related DiseasesConnective tissue disorders researchGenetic Associations and Epidemiology

BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians

Open access
Rueda, B, Gourh, P, Broen, J, Agarwal, S K, Simeon, C, Ortego-Centeno, N, Vonk, M C, Coenen, M +21 more·2010·Annals of the Rheumatic Diseases

Abstract

Objective To investigate the possible association of the BANK1 gene with genetic susceptibility to systemic sclerosis (SSc) and its subphenotypes. Methods A large multicentre case-control association study including 2380 patients with SSc and 3270 healthy controls from six independent case-control sets of Caucasian ancestry (American, Spanish, Dutch, German, Swedish and Italian) was conducted. Three putative functional BANK1 polymorphisms (rs17266594 T/C, rs10516487 G/A, rs3733197 G/A) were selected as genetic markers and genotyped by Taqman 5 allelic discrimination assay. Results A significant association of the rs10516487 G and rs17266594 T alleles with SSc susceptibility was observed (pooled OR=1.12, 95% CI 1.03 to 1.22; p=0.01 and pooled OR=1.14, 95% CI 1.05 to 1.25; p=0.003, respectively), whereas the rs3733197 genetic variant showed no statistically significant deviation. Stratification for cutaneous SSc phenotype showed that the BANK1 rs10516487 G, rs17266594 T and rs3733197 G alleles were strongly associated with susceptibility to diffuse SSc (dcSSc) (pooled OR=1.20, 95% CI 1.05 to 1.37, p=0.005; pooled OR=1.23, 95% CI 1.08 to 1.41, p=0.001; pooled OR=1.15, 95% CI 1.02 to 1.31, p=0.02, respectively). Similarly, stratification for specific SSc autoantibodies showed that the association of BANK1 rs10516487, rs17266594 and rs3733197 polymorphisms was restricted to the subgroup of patients carrying anti-topoisomerase I antibodies (pooled OR=1.20, 95% CI 1.02 to 1.41, p=0.03; pooled OR=1.24, 95% CI 1.05 to 1.46, p=0.01; pooled OR=1.26, 95% CI 1.07 to 1.47, p=0.004, respectively). Conclusion The results suggest that the BANK1 gene confers susceptibility to SSc in general, and specifically to the dcSSc and anti-topoisomerase I antibody subsets.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/ard.2009.118174

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • B cell adaptor protein with ankyrin repeats is a known risk factor in autoimmunity including SLE and systemic sclerosis.

    “B cell adaptor protein with ankyrin repeats is a known risk factor in autoimmunity including SLE and systemic sclerosis (113, 114).”

    From The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration (2021) · cites this paper as [114]

    The Introduction reports that BANK1 variants are associated with susceptibility to SLE, and the Discussion reports an association with diffuse systemic sclerosis in the studied Caucasian cohorts. The claim does not preserve the paper’s limitation to the diffuse form; the Discussion says the results suggest susceptibility to diffuse, but not limited, systemic sclerosis and calls for further replication. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 20

  1. [1]LeBien TW Tedder TF B lymphocytes: how they develop and function Blood 2008 112 1570 1580 18725575 PMC2518873
  2. [2]Zouali M B lymphocytes – chief players and therapeutic targets in autoimmune diseases Front Biosci 2008 13 4852 4861 18508550
  3. [3]Kozyrev SV Abelson AK Wojcik J Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus Nat Genet 2008 40 211 216 18204447
  4. [4]Orozco G Abelson AK González-Gay MA Study of functional variants of the BANK1 gene in rheumatoid arthritis Arthritis Rheum 2009 60 372 379 19180476
  5. [5]Agarwal SK Tan FK Arnett FC Genetics and genomic studies in scleroderma (systemic sclerosis) Rheum Dis Clin North Am 2008 34 17 40 18329530
  6. [6]Gu YS Kong J Cheema GS The immunobiology of systemic sclerosis Semin Arthritis Rheum 2008 38 132 160 18221988
  7. [7]Whitfield ML Finlay DR Murray JI Systemic and cell type-specific gene expression patterns in scleroderma skin Proc Natl Acad Sci USA 2003 100 12319 12324 14530402 PMC218756
  8. [8]Cepeda EJ Reveille JD Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance Curr Opin Rheumatol 2004 16 723 732 15577611
  9. [9]Zhernakova A van Diemen CC Wijmenga C Detecting shared pathogenesis from the shared genetics of immune-related diseases Nat Rev Genet 2009 10 43 55 19092835
  10. [10]Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 1980 23 581 590 7378088
  11. [11]LeRoy EC Medsger TA Jr Criteria for the classification of early systemic sclerosis J Rheumatol 2001 28 1573 1576 11469464
  12. [12]LeRoy EC Black C Fleischmajer R Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 1988 15 202 205 3361530
  13. [13]Rueda B Broen J Simeon C The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype Hum Mol Genet 2009 18 2071 2077 19286670
  14. [14]Gourh P Tan FK Assassi S Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis Arthritis Rheum 2006 54 3945 3953 17133608
  15. [15]Balding DJ A tutorial on statistical methods for population association studies Nat Rev Genet 2006 7 781 791 16983374
  16. [16]Aiba Y Yamazaki T Okada T BANK negatively regulates Akt activation and subsequent B cell responses Immunity 2006 24 259 268 16546095
  17. [17]Yokoyama K Su Ih IH Tezuka T BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor EMBO J 2002 21 83 92 11782428 PMC125810
  18. [18]Dieudé P Guedj M Wipff J The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis Arthritis Rheum 2008 58 2183 2188 18576360
  19. [19]Wu SP Leng L Feng Z Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma Arthritis Rheum 2006 54 3661 3669 17075815
  20. [20]Sato S Fujimoto M Hasegawa M Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis Mol Immunol 2004 41 1123 1133 15482848

Cited by

Sorted by citations

Authors
Rueda, B., Gourh, P., Broen, J., Agarwal, S. K., Simeon, C., Ortego-Centeno, N., Vonk, M. C., Coenen, M., Riemekasten, G., Hunzelmann, N., Hesselstrand, R., Tan, F. K., Reveille, J. D., Assassi, S., Garcia-Hernandez, F. J., Carreira, P., Camps, M., Fernandez-Nebro, A., de la Peña, P. G., Nearney, T., Hilda, D., Gónzalez-Gay, M. A., Airo, P., Beretta, L., Scorza, R., Radstake, T. R. D. J., Mayes, M. D., Arnett, F. C., & Martin, J.
Affiliations
  • The University of Texas Health Science Center at Houston (US)
  • Radboud University Medical Center (NL)
  • Charité – Universitätsmedizin Berlin (DE)
  • University of Cologne (DE)
  • Lund University (SE)
  • Hospital Universitario 12 De Octubre (ES)
  • The University of Texas Medical Branch at Galveston (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Milan (IT)
  • Instituto de Parasitología y Biomedicina "López - Neyra" (ES)
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2010-05
Volume
69
Issue
4
Pages
700-705
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2124910352
Cited by
108
References
0
Citations by year
2025: 1 · 2024: 6 · 2023: 1 · 2022: 3 · 2021: 8 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 12 · 2015: 13 · 2014: 5 · 2013: 10 · 2012: 7
FWCI
7.54
Type
journal article
Language
en
Update notices
erratum (2011-05-01)
Open access
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • Arthritis Foundation
  • Dutch Arthritis Association
  • National Institutes of Health (5p50ar054144-05, n01ar002251-000)
  • Instituto de Salud Carlos III
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P50-AR-054144, R01AR055258, N01 AR 02251, K08AR054404)
  • National Center for Research Resources (UL1RR024148)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
systemic sclerosis, diffuse cutaneous systemic sclerosis, genetic susceptibility, single nucleotide polymorphisms, anti-Scl-70 antibodies, anti-RNA polymerase III antibodies, autoantibodies, genetic association
MeSH terms
Autoantibodies, Gene Frequency, Genotype, Humans, Membrane Proteins, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Scleroderma, Diffuse, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review